|
|
| Phases of Development | Preclinical | Phase I | Phase I/II | Phase II | Pivotal | Phase III | Phase IV | Approved | Marketed |
|---|
| Autoimmune | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | | Dermatology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | | Genitourinary | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | | Infectious | 4 | 3 | 1 | 6 | 1 | 4 | 1 | 1 | 7 | | Inflammation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | Ophthalmic | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | | Pulmonary | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Ribosomal 50S subunit